Missed Diagnosis of Cystic Fibrosis in India
Cystic fibrosis is not rare in India. It is rarely identified. India is thought to have the largest number of undiagnosed cases of any country in the world, and the reasons are practical rather than biological: what doctors were taught to expect, what other illnesses look like, and what tests a family can actually reach.
The scale of the problem
For decades the medical community widely believed cystic fibrosis was absent, or vanishingly rare, in populations that were not white.12 That belief was never tested against evidence from India itself. It was undone largely by studying South Asian migrant communities in the United Kingdom and United States, where incidence among people of Indian origin was estimated at somewhere between one in 10,000 and one in 40,000.1
Applied to India's birth rate, those figures imply that somewhere between 3,000 and 37,000 children are born with cystic fibrosis in India every year.3 Very few of them are diagnosed. That combination, a substantial birth cohort and a very low diagnosis rate, is why India is described as having the largest absolute number of undiagnosed cystic fibrosis cases in the world.3
The median age of diagnosis in India falls somewhere between two and ten and a half years, depending on the cohort studied. In the United States the figure is around 2.6 months, and in Europe around 3.6 months.47 Those missing years are not neutral. In one Indian series of infants diagnosed with cystic fibrosis, 41 percent had died, at a median age of five months.5 Many children die of CF complications in India before anyone establishes what they had.
Why cystic fibrosis gets missed
Five things compound each other. None of them is about the disease behaving differently in India.
1. Inherited assumptions about who gets CF
Medical textbooks framed cystic fibrosis as a disease of white European populations for a long time, and that framing shaped what generations of clinicians looked for. The practical result was that CF simply did not appear on the list of possibilities for a child with a chronic chest or digestive illness.12
This is changing. In a survey of pediatricians attending a CF training workshop in Pune, 92.5 percent agreed that CF is now a panethnic disease, and 90 percent agreed that educating pediatricians about it would improve survival and quality of life.8 Awareness is moving faster than infrastructure.
2. Cystic fibrosis looks like more common illnesses
CF presents with chronic cough, repeated pneumonia, failure to gain weight, and poor absorption of food. In a setting where tuberculosis and severe malnutrition are common, those symptoms point somewhere else first, and a diagnosis that fits the local pattern is usually reached before a rare genetic condition is considered.13
| Diagnosis given | Why it fits | What follows |
|---|---|---|
| Pulmonary tuberculosis | Persistent cough and chest X-ray changes are consistent with TB, which is far more common. | Children are placed on empirical anti-tubercular therapy, sometimes for months or years, before CF is considered.13 |
| Severe acute malnutrition | Failure to thrive and poor absorption are attributed to poverty, diet, or celiac disease. | Nutritional treatment is given without enzyme replacement, so it does not work, and the underlying cause stays hidden.1 |
| Asthma or chronic bronchitis | Recurrent wheeze and lower respiratory infections resemble childhood asthma or post-infectious bronchiectasis. | Inhalers and antibiotic courses are given repeatedly without airway clearance or CF-specific care.3 |
| Primary immunodeficiency | Repeated bacterial infection, often with Pseudomonas aeruginosa or Staphylococcus aureus, suggests an immune defect. | Immunological investigation proceeds down the wrong path while the airway problem continues untreated.1 |
The pattern worth noticing is that each of these is a reasonable first guess. What goes wrong is not the initial diagnosis so much as the absence of a second look when treatment does not work.
Indian pediatricians surveyed identified the situations that should prompt suspicion of CF: severe malnutrition that does not respond to nutritional therapy, meconium ileus in a newborn, and recurrent pneumonia.8 If a child is being treated for something and not improving, that is the moment the question is worth asking again.
3. No national newborn screening
In high-income countries, an immunoreactive trypsinogen blood spot test taken shortly after birth flags infants who need further testing, which is why diagnosis there typically happens within the first few months of life. India has no national newborn screening program for cystic fibrosis.34
Without it, diagnosis depends entirely on a clinician suspecting CF and pursuing it. That makes every one of the other four problems on this page matter more, because there is no safety net underneath them.
4. The tests exist in very few places
The two tests that establish a diagnosis are quantitative pilocarpine iontophoresis sweat chloride testing and CFTR genetic sequencing. Both are available at only a small number of tertiary centers, concentrated in major cities.3
For a family in a rural or semi-urban area, reaching one of those centers means travel, cost, and time away from work. In the Pune survey, 90 percent of pediatricians reported having no access to sweat chloride testing or genetic studies, and 87.5 percent said that this unavailability made diagnosing CF difficult.8 The conclusion drawn by those authors was direct: inadequate diagnostic services are themselves a reason CF cases are missed in India.8
5. Genetic panels built for other populations
In western populations, a single variant called F508del accounts for the large majority of CF-causing mutations, on the order of 70 to 80 percent. Indian patients show far greater genetic variety: F508del accounts for only about 19 to 34 percent of mutations in Indian cohorts.137
This matters because commercial targeted mutation panels were designed around the variants common in European populations. Run on an Indian patient, such a panel can easily come back negative in someone who does have cystic fibrosis. Establishing the diagnosis then requires sequencing the whole gene, which is considerably more expensive and out of reach for most families.310
This is the single most useful thing on this page for a family already in the system. If a targeted genetic panel came back negative but the clinical picture still fits cystic fibrosis, that result does not close the question. Sweat chloride testing remains central, and extended sequencing may be needed.10
What late diagnosis looks like
Because diagnosis so often comes years after symptoms begin, children in India frequently arrive at it already carrying advanced, sometimes life-threatening complications.16
| Complication | What is happening |
|---|---|
| Pseudo-Bartter syndrome | Severe salt loss through sweat in hot weather produces a metabolic disturbance with low sodium, low potassium, and alkalosis. It can be the presenting emergency.1 |
| Advanced malnutrition | Severely low blood protein, swelling, anemia, and deficiency of the fat-soluble vitamins A, D, E, and K.16 |
| Early Pseudomonas colonization | Chronic Pseudomonas aeruginosa lung infection is often already established at diagnosis, because years passed with no airway clearance.6 |
The significance of chronic Pseudomonas at first diagnosis is worth spelling out. When it is caught early it can often be eradicated. Once established, it usually cannot, and treatment shifts permanently to holding it back. A diagnostic delay therefore does not just postpone treatment. It can remove options that would otherwise have existed. See knowing when something is wrong.
Late diagnosis is not only a childhood problem. Cystic fibrosis is increasingly being identified in adolescents and adults in India, in people who lived for years with a different label attached to their illness.9 An adult with unexplained bronchiectasis, chronic sinus disease, and poor absorption of food is exactly the sort of patient in whom CF has historically been missed.9
What helps
If you suspect cystic fibrosis in yourself or your child, or you are being treated for something that is not improving, these are the things worth pressing for.
- Ask specifically for a sweat chloride test, and ask for it at a center that performs the test regularly. A test done rarely is more likely to need repeating.3
- Say out loud that CF has not been excluded. Naming it as a possibility is often what gets it investigated, given how far down the list it has historically sat.1
- If a genetic panel was negative, ask what it actually tested for. Targeted panels miss variants common in Indian patients.3
- Flag treatment failure explicitly. Malnutrition that does not respond to feeding, or a chest problem that does not respond to TB treatment, is diagnostic information in itself.8
- Contact a patient organization. The Cystic Fibrosis Trust of India maintains information on which centers provide specialist care and how to reach them.11
Understanding cystic fibrosis explains what the condition is and how it is inherited. Regional Resources lists specialist centers and patient organizations in India and elsewhere.
Sources
Numbered markers in the text link to the entries below.
- Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatric Pulmonology, 2007; 42(12): 1087 to 1094
- Prasad R, Sharma H, Kaur G. Molecular basis of cystic fibrosis disease: an Indian perspective. Indian Journal of Clinical Biochemistry, 2010; 25(4): 335 to 341
- Purushothaman AK, Natarajan S, Panigrahi T, Nelson EJR. Diagnosis and treatment of cystic fibrosis in India: what is at stake for developing countries? Journal of Biosciences, 2024; 49(3): article 64
- India: the last and best frontier for cystic fibrosis newborn screening, with perspectives on special challenges
- Exceptionally high cystic fibrosis-related morbidity and mortality in infants and young children in India: the need for newborn screening and CF-specific capacity building
- Clinical profile of cystic fibrosis in India: a multi-centric prospective study, Journal of Paediatrics and Child Health
- Clinical profile, diagnostic delay, and genetic make-up of cystic fibrosis in Kashmir, India
- Cystic fibrosis: are we missing the diagnosis in India? Survey of paediatricians in Pune, Maharashtra
- Diagnosis of cystic fibrosis beyond childhood in India
- Diagnosing cystic fibrosis in low- and middle-income countries: challenges and strategies
- Cystic Fibrosis Trust of India
Incidence estimates for cystic fibrosis in India vary widely between studies, and the figures above are given as ranges for that reason. This page has not been reviewed by a clinician (see the disclaimer below).